Raymond James Financial Services Advisors, Inc. - AIM IMMUNOTECH INC ownership

AIM IMMUNOTECH INC's ticker is AIM and the CUSIP is 00901B105. A total of 40 filers reported holding AIM IMMUNOTECH INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Raymond James Financial Services Advisors, Inc. ownership history of AIM IMMUNOTECH INC
ValueSharesWeighting
Q4 2022$11,525
-47.6%
36,9500.0%0.00%
Q3 2022$22,000
-24.1%
36,950
-1.3%
0.00%
Q2 2022$29,000
-35.6%
37,450
-22.7%
0.00%
Q4 2021$45,000
-54.1%
48,4500.0%0.00%
Q3 2021$98,000
-4.9%
48,450
+1.0%
0.00%
Q2 2021$103,00047,9500.00%
Other shareholders
AIM IMMUNOTECH INC shareholders Q2 2021
NameSharesValueWeighting ↓
ForthRight Wealth Management, LLC 20,000$9,1000.00%
D.B. Root & Company, LLC 12,050$5,4830.00%
SeaCrest Wealth Management, LLC 37,063$16,8640.00%
SNS Financial Group, LLC 10,000$4,5500.00%
Virtu Financial LLC 29,061$130.00%
VisionPoint Advisory Group, LLC 3,142$1,4300.00%
Community Bank, N.A. 13,226$5,9510.00%
Verition Fund Management LLC 148,000$67,3400.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 108,900$49,5500.00%
Traynor Capital Management, Inc. 11,777$5,3590.00%
View complete list of AIM IMMUNOTECH INC shareholders